Tekla Capital Management LLC Avrobio, Inc. Transaction History

Tekla Capital Management LLC

  • $2.53 Billion
  • Q2 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$12.99 - $19.41 $1.83 Million - $2.73 Million
-140,581 Closed
0 $0
Q2 2020

Aug 13, 2020
BUY
$12.19 - $22.96 $800,968 - $1.51 Million
65,707 Added 87.76%
140,581 $2.45 Million
Q4 2019

Feb 13, 2020
BUY
$13.05 - $21.88 $713,808 - $1.2 Million
54,698 Added 271.1%
74,874 $1.51 Million
Q3 2019

Nov 13, 2019
BUY
$14.12 - $23.44 $284,885 - $472,925
20,176 New
20,176 $285,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Tekla Capital Management LLC Portfolio

Follow Tekla Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email